Unaudited NAV for July 2022 (1419021)

Arix Bioscience PLC (ARIX) Unaudited NAV for July 2022 12-Aug-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Arix Bioscience plc

Unaudited NAV for July 2022

LONDON, 12 August 2022: Arix Bioscience plc ("Arix" or the "Company") (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, announces the unaudited Net Asset Value ("NAV") of the Company for the date ended 31 July 2022 as follows:

              NAV Breakdown 
Date                                                                      Total NAV 
              Listed Portfolio Unlisted Portfolio Cash    Other Interests           NAV per share 
31 July 22 
              GBP38.5m           GBP55.7m             GBP130.8m GBP2.0m           GBP227.0m   GBP1.76 
(unaudited) 

[ENDS]

Enquiries

For more information on Arix, please contact:

Arix Bioscience plc

[phone]

[e-mail]

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil, Nick Johnson

[phone]

[e-mail]

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

-----------------------------------------------------------------------------------------------------------------------

ISIN:           GB00BD045071 
Category Code:  MSCM 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:   180898 
EQS News ID:    1419021 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1419021&application_name=news

(END) Dow Jones Newswires

August 12, 2022 02:00 ET (06:00 GMT)